
Dove Medical Press Ltd is an online open access academic publisher specialising in science, technology and especially medicine. All 80 peer-reviewed journals are free to access online, allowing authors to disseminate their research to a global audience. Most of our journals are widely indexed in databases such as PubMed, Scopus and DOAJ, and an increasing number have Impact Factors. We are a member of OASPA, COPE and HINARI, and are committed to publishing good scientific research and giving authors around the world the opportunity to publish and share their research findings. We have an efficient and rigorous peer-review process. Due to this, many of our journals are able to provide authors with an initial editorial decision within four to five weeks. We aim to provide the highest possible standard of service to our authors. Recent feedback from an author survey demonstrated that: • 100% of authors surveyed found the online manuscript system easy to use • 100% of authors surveyed agreed that they received professional accurate service • 97% of authors surveyed would submit a manuscript with us again • 96% of authors surveyed received prompt communication throughout the publishing process • 86% of authors surveyed rated their level of satisfaction as Excellent (the other 14% rated us as good) To view testimonials from more of our authors please visit: https://www.dovepress.com/testimonials.php We have offices in the United Kingdom, USA and New Zealand. Dove Medical Press is part of Taylor & Francis Group, the Academic Publishing Division of Informa PLC.
過去 90 日內有 1 個訊號。
此公司進入各市場的次序 — 由最舊至最新
和鉑醫藥宣布HBM9378的I期臨床試驗結果積極
註冊以查看完整訊號動態
Dove Medical Press 的國際擴張與競爭對手的比較
長條顯示所比較各公司之間的相對規模。
欄位5| 公司 | 市場 | 新市場 | 動能 | 活動 | 擴張評分 |
|---|---|---|---|---|---|
Dove Medical Press你 | 1 | 1 | -100% | 1 | 11 |
目前並無招聘
註冊以追蹤此公司,並在發生變化時第一時間獲得提醒。
無進行中的廣告活動
註冊以追蹤此公司,並在發生變化時第一時間獲得提醒。
和鉑醫藥的HBM9378(針對TSLP的新型抗體)I期試驗顯示良好安全性和延長半衰期,支持進一步開發用於嚴重免疫疾病。
研究發現結合ESR和CRP測試可減少誤診,為739張床位的醫院每年節省995萬美元,挑戰取消ESR測試的呼聲。
解鎖已驗證電郵與直撥電話
免費 · 無需信用卡
關於 Dove Medical Press 業務、市場及增長訊號的快速解答。
